title: Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential.
abstract: In 2010, all young patients treated for intrathoracic Hodgkin lymphoma (HL) at one of 10 radiotherapy centers in the province of Quebec received 3D conformal photon therapy. These patients may now be at risk for late effects of their treatment, notably secondary malignancies and cardiac toxicity. We hypothesized that more complex radiotherapy, including intensity-modulated proton therapy (IMPT) and possibly IMRT (in the form of helical tomotherapy (HT)), could benefit these patients. With institutional review board approval at 10 institutions, all treatment plans for patients under the age of 30 treated for HL during a six-month consecutive period of 2010 were retrieved. Twenty-six patients were identified, and after excluding patients with extrathoracic radiation or treatment of recurrence, 20 patients were replanned for HT and IMPT. Neutron dose for IMPT plans was estimated from published measurements. The relative seriality model was used to predict excess risk of cardiac mortality. A modified linear quadratic model was used to predict the excess absolute risk for induction of lung cancer and, in female patients, breast cancer. Model parameters were derived from published data. Predicted risk for cardiac mortality was similar among the three treatment techniques (absolute excess risk of cardiac mortality was not reduced for HT or IMPT (p > 0.05, p > 0.05) as compared to 3D CRT). Predicted risks were increased for HT and reduced for IMPT for secondary lung cancer (p < 0.001, p < 0.001) and breast cancers (p< 0.001, p< 0.001) as compared to 3D CRT.
authors.affiliation: McGill University. allison.toltz@mail.mcgill.ca.
authors.forename: Allison
authors.initials: A
authors.lastname: Toltz
authors.forename: Naomi
authors.initials: N
authors.lastname: Shin
authors.forename: Ellis
authors.initials: E
authors.lastname: Mitrou
authors.forename: Cecile
authors.initials: C
authors.lastname: Laude
authors.forename: Carolyn R
authors.initials: CR
authors.lastname: Freeman
authors.forename: Jan
authors.initials: J
authors.lastname: Seuntjens
authors.forename: William
authors.initials: W
authors.lastname: Parker
authors.forename: David
authors.initials: D
authors.lastname: Roberge
mesh_terms: D000293:Adolescent; D000328:Adult; D066126:Cardiotoxicity / Q000401:mortality*; D005260:Female; D006689:Hodgkin Disease / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009381:Neoplasms, Radiation-Induced / Q000209:etiology*; D058958:Organs at Risk / Q000528:radiation effects*; D017785:Photons / Q000009:adverse effects*; D011379:Prognosis; D011832:Radiation Injuries / Q000209:etiology*; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D020266:Radiotherapy, Conformal / Q000009:adverse effects*; D050397:Radiotherapy, Intensity-Modulated / Q000009:adverse effects; D055815:Young Adult